REPORT ID 6257

EMEA (Europe, Middle East and Africa) Marburgvirus Infection Market Report 2017

Publish Date
25-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the EMEA Marburgvirus Infection market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Marburgvirus Infection for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Marburgvirus Infection market competition by top manufacturers/players, with Marburgvirus Infection sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Arno Therapeutics Inc
    BioCryst Pharmaceuticals Inc
    Eisai Co Ltd
    Emergent BioSolutions Inc
    Fab'entech SA
    Integrated BioTherapeutics Inc
    Johnson & Johnson
    NanoViricides Inc
    Profectus BioSciences Inc
    Rodos BioTarget GmbH
    Sarepta Therapeutics Inc
    Theravectys SA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Eritoran Tetrasodium
    AR-12
    ARD-5
    AVI-7288
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Marburgvirus Infection Market Report 2017
1 Marburgvirus Infection Overview
    1.1 Product Overview and Scope of Marburgvirus Infection
    1.2 Classification of Marburgvirus Infection
        1.2.1 EMEA Marburgvirus Infection Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Marburgvirus Infection Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Eritoran Tetrasodium
        1.2.4 AR-12
        1.2.5 ARD-5
        1.2.6 AVI-7288
        1.2.7 Others
    1.3 EMEA Marburgvirus Infection Market by Application/End Users
        1.3.1 EMEA Marburgvirus Infection Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 EMEA Marburgvirus Infection Market by Region
        1.4.1 EMEA Marburgvirus Infection Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Marburgvirus Infection (2012-2022)
        1.5.1 EMEA Marburgvirus Infection Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Marburgvirus Infection Revenue and Growth Rate (2012-2022)

2 EMEA Marburgvirus Infection Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Marburgvirus Infection Market Competition by Players/Manufacturers
        2.1.1 EMEA Marburgvirus Infection Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Marburgvirus Infection Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Marburgvirus Infection Sale Price by Players (2012-2017)
    2.2 EMEA Marburgvirus Infection (Volume and Value) by Type/Product Category
        2.2.1 EMEA Marburgvirus Infection Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Marburgvirus Infection Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Marburgvirus Infection Sale Price by Type (2012-2017)
    2.3 EMEA Marburgvirus Infection (Volume) by Application
    2.4 EMEA Marburgvirus Infection (Volume and Value) by Region
        2.4.1 EMEA Marburgvirus Infection Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Marburgvirus Infection Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Marburgvirus Infection Sales Price by Region (2012-2017)

3 Europe Marburgvirus Infection (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Marburgvirus Infection Sales and Value (2012-2017)
        3.1.1 Europe Marburgvirus Infection Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Marburgvirus Infection Revenue and Growth Rate (2012-2017)
    3.2 Europe Marburgvirus Infection Sales and Market Share by Type
    3.3 Europe Marburgvirus Infection Sales and Market Share by Application
    3.4 Europe Marburgvirus Infection Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Marburgvirus Infection Sales Volume by Countries (2012-2017)
        3.4.2 Europe Marburgvirus Infection Revenue by Countries (2012-2017)
        3.4.3 Germany Marburgvirus Infection Sales and Growth Rate (2012-2017)
        3.4.4 France Marburgvirus Infection Sales and Growth Rate (2012-2017)
        3.4.5 UK Marburgvirus Infection Sales and Growth Rate (2012-2017)
        3.4.6 Russia Marburgvirus Infection Sales and Growth Rate (2012-2017)
        3.4.7 Italy Marburgvirus Infection Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Marburgvirus Infection Sales and Growth Rate (2012-2017)

4 Middle East Marburgvirus Infection (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Marburgvirus Infection Sales and Value (2012-2017)
        4.1.1 Middle East Marburgvirus Infection Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Marburgvirus Infection Revenue and Growth Rate (2012-2017)
    4.2 Middle East Marburgvirus Infection Sales and Market Share by Type
    4.3 Middle East Marburgvirus Infection Sales and Market Share by Application
    4.4 Middle East Marburgvirus Infection Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Marburgvirus Infection Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Marburgvirus Infection Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Marburgvirus Infection Sales and Growth Rate (2012-2017)
        4.4.4 Israel Marburgvirus Infection Sales and Growth Rate (2012-2017)
        4.4.5 UAE Marburgvirus Infection Sales and Growth Rate (2012-2017)
        4.4.6 Iran Marburgvirus Infection Sales and Growth Rate (2012-2017)

5 Africa Marburgvirus Infection (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Marburgvirus Infection Sales and Value (2012-2017)
        5.1.1 Africa Marburgvirus Infection Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Marburgvirus Infection Revenue and Growth Rate (2012-2017)
    5.2 Africa Marburgvirus Infection Sales and Market Share by Type
    5.3 Africa Marburgvirus Infection Sales and Market Share by Application
    5.4 Africa Marburgvirus Infection Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Marburgvirus Infection Sales Volume by Countries (2012-2017)
        5.4.2 Africa Marburgvirus Infection Revenue by Countries (2012-2017)
        5.4.3 South Africa Marburgvirus Infection Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Marburgvirus Infection Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Marburgvirus Infection Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Marburgvirus Infection Sales and Growth Rate (2012-2017)

6 EMEA Marburgvirus Infection Manufacturers/Players Profiles and Sales Data
    6.1 Arno Therapeutics Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Marburgvirus Infection Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Arno Therapeutics Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 BioCryst Pharmaceuticals Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Marburgvirus Infection Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eisai Co Ltd
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Marburgvirus Infection Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eisai Co Ltd Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Emergent BioSolutions Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Marburgvirus Infection Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Emergent BioSolutions Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Fab'entech SA
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Marburgvirus Infection Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Fab'entech SA Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Integrated BioTherapeutics Inc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Marburgvirus Infection Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Johnson & Johnson
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Marburgvirus Infection Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson & Johnson Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 NanoViricides Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Marburgvirus Infection Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 NanoViricides Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Profectus BioSciences Inc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Marburgvirus Infection Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Profectus BioSciences Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Rodos BioTarget GmbH
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Marburgvirus Infection Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Rodos BioTarget GmbH Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Sarepta Therapeutics Inc
    6.12 Theravectys SA

7 Marburgvirus Infection Manufacturing Cost Analysis
    7.1 Marburgvirus Infection Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Marburgvirus Infection

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Marburgvirus Infection Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Marburgvirus Infection Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Marburgvirus Infection Market Forecast (2017-2022)
    11.1 EMEA Marburgvirus Infection Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Marburgvirus Infection Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Marburgvirus Infection Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Marburgvirus Infection Price and Trend Forecast (2017-2022)
    11.2 EMEA Marburgvirus Infection Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Marburgvirus Infection Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Marburgvirus Infection Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Marburgvirus Infection Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Marburgvirus Infection Sales Forecast by Type (2017-2022)
    11.7 EMEA Marburgvirus Infection Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer